Fri 16'th Nov 2018
Rocket Pharmaceuticals Inc Stock Analysis
Technical stock analysis for Fri 16'th Nov 2018
Rocket Pharmaceuticals Inc gained 0.35% in the last trading day, rising from $14.20 to $14.25 The price has fallen in 7 of the last 10 days and is down by -20.21% for this period. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 11 380 more shares were traded than the day before. In total, 266 706 shares bought and sold for approximately $3.80 million.
Rocket Pharmaceuticals Inc lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $14.02 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -29.83% during the next 3 months and, with 90% probability hold a price between $9.84 and $14.07 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday November 15, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Rocket Pharmaceuticals Inc holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $15.34 and $18.22. A break-up above any of these levels will issue buy signals.
Relative Strength Index (RSI)
RSI14 is 38 and the stock is currently not being overbought or oversold
Support & Resistance
Rocket Pharmaceuticals Inc finds support from accumulated volume at $14.23.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.60 between high and low, or 4.36%. For the last week, the stock has had a daily average volatility of 7.17%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Rocket Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Sell Candidate.
|RCKT $14.25 $0.05(0.35%)|
RCKT is up $0.05 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for RCKT based on the 1-3 month system that more than doubles the S&P 500.
Click here – the RCKT analysis is free »